ReOxy is a new breathing therapy medical device, that treats a patient with individually dosed levels of reduced-oxygen (hypoxic) gas mixtures throughout the procedure.
The main objective to be achieved with use of the ReOxy device is short and long-term adaptive response at systemic, organic, tissue and cellular levels. These compensatory mechanisms of adaptation have been scientifically proven to effectively treat cardiovascular and metabolic diseases.
ReOxy uses Self Regulated Treatment (SRT) technology. SRT-technology relies upon the principle of biological feedback, where patient bodily reaction define therapeutic parameters and controls them throughout the whole treatment session.
ReOxy breathing therapy device is a device that was developed based on latest developments in medical devices and electronics.
ReOxy is manufactured by Bitmos GmbH and is CE marked and produced in full compliance to 93/42/EEC (Medical Devices Directive – MDD), facilitating high quality and safety of operation.
Only use the ReOxy after a medical indication and only in compliance with the doctor's prescription by following instructions for use.
If side effects or extreme health restrictions occur during the therapy, you should immediately consult your doctor.